Intensive Lifestyle Changes for Reversal
of Coronary Heart Disease
DeanOrnish,MD;LarryW.Scherwitz,PhD;JamesH.Billings,PhD,MPH;K.LanceGould,MD;
TerriA.Merritt,MS;StephenSparler,MA;WilliamT.Armstrong,MD;ThomasA.Ports,MD;
RichardL.Kirkeeide,PhD;CharissaHogeboom,PhD;RichardJ.Brand,PhD
Context.—The Lifestyle Heart Trial demonstrated that intensive lifestyle THELIFESTYLEHeartTrialwasthe
changesmayleadtoregressionofcoronaryatherosclerosisafter1year. firstrandomizedclinicaltrialtoinvesti-
Objectives.—Todeterminethefeasibilityofpatientstosustainintensivelifestyle gatewhetherambulatorypatientscould
changesforatotalof5yearsandtheeffectsoftheselifestylechanges(without bemotivatedtomakeandsustaincom-
prehensivelifestylechangesand,ifso,
lipid-loweringdrugs)oncoronaryheartdisease.
whether the progression of coronary
Design.—Randomized controlled trial conducted from 1986 to 1992 using a
atherosclerosiscouldbestoppedorre-
randomizedinvitationaldesign.
versed without using lipid-lowering
Patients.—Forty-eightpatientswithmoderatetoseverecoronaryheartdisease
drugs as measured by computer-as-
wererandomizedtoanintensivelifestylechangegrouportoausual-carecontrol sistedquantitativecoronaryarteriogra-
group,and35completedthe5-yearfollow-upquantitativecoronaryarteriography. phy. This study derived from earlier
Setting.—Twotertiarycareuniversitymedicalcenters. studies that used noninvasive mea-
Intervention.—Intensivelifestylechanges(10%fatwholefoodsvegetariandiet, sures.1,2
aerobicexercise,stressmanagementtraining,smokingcessation,grouppsycho- After 1 year, we found that experi-
socialsupport)for5years. mentalgroupparticipantswereableto
make and maintain intensive lifestyle
MainOutcomeMeasures.—Adherencetointensivelifestylechanges,changes
changes and had a 37.2% reduction in
incoronaryarterypercentdiameterstenosis,andcardiacevents.
low-density lipoprotein (LDL) choles-
Results.—Experimental group patients (20 [71%] of 28 patients completed
terollevelsanda91%reductioninthe
5-year follow-up) made and maintained comprehensive lifestyle changes for 5 frequencyofanginalepisodes.3Average
years,whereascontrolgrouppatients(15[75%]of20patientscompleted5-year percent diameter stenosis regressed
follow-up)mademoremoderatechanges.Intheexperimentalgroup,theaverage from40.0%atbaselineto37.8%1year
percentdiameterstenosisatbaselinedecreased1.75absolutepercentagepoints later,achangethatwascorrelatedwith
after1year(a4.5%relativeimprovement)andby3.1absolutepercentagepoints the degree of lifestyle change. In con-
after5years(a7.9%relativeimprovement).Incontrast,theaveragepercentdiam- trast,patientsintheusual-carecontrol
eterstenosisinthecontrolgroupincreasedby2.3percentagepointsafter1year groupmademoremoderatechangesin
lifestyle,reducedLDLcholesterollev-
(a5.4%relativeworsening)andby11.8percentagepointsafter5years(a27.7%
elsby6%,andhada165%increaseinthe
relativeworsening)(P=.001betweengroups.Twenty-fivecardiaceventsoccurred
frequencyofreportedanginalepisodes.
in28experimentalgrouppatientsvs45eventsin20controlgrouppatientsduring
Averagepercentdiameterstenosispro-
the5-yearfollow-up(riskratioforanyeventforthecontrolgroup,2.47[95%con-
gressedfrom42.7%to46.1%.
fidenceinterval,1.48-4.20]). Given these encouraging findings,
Conclusions.—More regression of coronary atherosclerosis occurred after 5 weextendedthestudyforanadditional
yearsthanafter1yearintheexperimentalgroup.Incontrast,inthecontrolgroup, 4yearstodetermine(1)thefeasibility
coronaryatherosclerosiscontinuedtoprogressandmorethantwiceasmanycar- ofpatientssustainingintensivechanges
diaceventsoccurred. in diet and lifestyle for a much longer
time,and(2)theeffectsofthesechanges
JAMA.1998;280:2001-2007
on risk factors, coronary atherosclero-
sis, myocardial perfusion, and cardiac
FromtheDepartmentofMedicine(DrOrnish),and Division of Cardiology, University of Texas Medical eventsafter4additionalyears.
theDivisionofCardiology(DrArmstrong),California School,Houston(DrsGouldandKirkeeide);andthe
PacificMedicalCenter,SanFrancisco;theDepartment PreventiveMedicineResearchInstitue,Sausalito,Calif METHODS
ofMedicine(DrOrnish),theDivisionofCardiology, (DrsOrnishScherwitz,andBillings,MrSparler,and
Cardiac Catheterization Laboratory, Cardiovascular MsMerritt). The design, recruitment, and study
Research Institute (Dr Ports), and the Division of Reprints:DeanOrnish,MD,PreventiveMedicineRe- populationwerepreviouslydescribed.3-5
Biostatistics (Drs Brand and Hogeboom), School of searchInstitute,900Bridgeway,Suite1,Sausalito,CA
Medicine,UniversityofCalifornia,SanFrancisco;the 94965(e-mail:DeanOrnish@aol.com). Inbrief,werecruitedmenandwomen
JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal 2001
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
Table1.—BaselineCharacteristicsofExperimentalandControlGroups* form after being fully informed of the
studyrequirements.
Experimental Control P
Patientscompleteda3-daydietdiary
Characteristic (n=20) (n=15) Value
Men,No. 20 12 at baseline and after 1 and 5 years to
.07 assess nutrient intake and dietary ad-
Women,No. 0 3
herence.6Methodsoflipidassayswere
Age,mean(SD),y 57.4(6.4) 61.8(7.5) .08
Education,mean(SD),y 15.5(2.7) 14.5(3.4) .29
thesameaspreviouslyreported.3These
Employed,No. 14 6 .10 3-daydietdiarieswereanalyzedwitha
Bodymassindex,mean(SD),kg/m2 28.4(4.1) 25.4(3.5) .03 software package (CBORD Diet Ana-
No.withhistoryofmyocardialinfarction 12 5 .17 lyzer;CBORDGroupInc;Ithaca,NY)
AverageNo.oflesionsstudied,mean(SD) 5.3(2.7) 5.3(3.2) .93 using the US Department of Agricul-
No.withhistoryofpercutaneoustransluminal 5 4 (cid:46).99 turedatabase.Also,patientswereasked
coronaryangioplasty to complete a questionnaire reporting
No.withhistoryofcoronaryarterybypassgraft 1 0 (cid:46).99 thefrequencyanddurationofexercise
Reportedangina,No.(%) 11(55) 6(40) .49 and of each stress management tech-
nique. Information from these sources
*Valuesarestatisticsunlessotherwiseindicated.Pvaluesare2-tailed.
wasquantifiedintocontinuousscoresus-
with coronary atherosclerosis docu- to5-yearcomparisons. inganapriorideterminedformula.The
mentedbyquantitativecoronaryarte- Four experimental and 4 control pa- adherence measure was a continuous
riography. tientswhohadanangiogramat1yeardid score reflecting daily intake of choles-
We identified 193 patients as poten- nothaveathirdangiogramafter5years. terol (in milligrams), fat (in grams),
tiallyeligibleforourstudywhoagreed Threeofthese4patientsintheexperi- frequencyanddurationofexercise,fre-
toundergoquantitativecoronaryangi- mentalgrouprefusedathirdangiogram quencyanddurationofstressmanage-
ography. Following angiography, 93 (patients only volunteered for a 1-year menttechniques,andsmoking.Ascore
patientsremainedeligibleandwereran- studythatwassubsequentlyextended), of 1.0 equalled 100% adherence but
domlyassignedtoexperimentalorcon- and1diedbetweenyears1and4;ofthe4 scorescouldbegreaterthan1.0ifpar-
trolgroupsusingarandomizedinvita- control group patients who did not un- ticipantsexceededtherecommendedin-
tional design to minimize crossover, dergoathirdangiogram,1died,2under- tensivelifestylechanges.
ethical concerns, nocebo effects, and went revascularization of the arterial The technicians responsible for per-
dropout.Ofthese93patientswhowere lesions under study, and 1 developed formingallmedicaltestswereblindedto
eligible, 53 were randomly assigned to Parkinsondiseaseandbecametooillto patientgroupassignment.Also,different
the experimental group and 40 to the besafelytested.Cinearteriogramsmade personnel implemented the lifestyle in-
usual-carecontrolgroup.Patientswere inSanFrancisco,Calif,weresenttothe tervention,conductedthetests,andcom-
thencontactedandinvitedtoparticipate University of Texas Medical School, putedstatisticalanalyses,althoughthedi-
in the study; 28 (53%) and 20 (50%) Houston,forblindedquantitativeanaly- etitian was made aware of the nutrient
agreedtoparticipateintheexperimen- sesaspreviouslydescribedindetail.4 analysistomonitorpatients’safetyand
talandcontrolgroups,respectively.The Allresults,exceptlesionchangesat1 adherence. Quantitative coronary arte-
primaryreasonforrefusalintheexperi- year (18 experimental and 15 control riogramswereblindlyanalyzedwithout
mental group was not wanting to un- subjects) and cardiac events after 5 knowledgeofgroupassignment.
dergointensivelifestylechangesand/or years(all28experimentaland20control
ProgramIntervention
not wanting a second coronary angio- subjects), are based on the total of 35
gram;controlpatientsrefusedprimarily patients(20experimentaland15control Experimental group patients were
becausetheydidnotwanttoundergoa subjects)whohadbothbaselineand5- prescribed an intensive lifestyle pro-
secondangiogram.Todetectpossiblese- year angiograms. From these 35 pa- gramthatincludeda10%-fatvegetarian
lectionbiases,wecollecteddataonage, tients,therewere224lesionsstudiedat diet, moderate aerobic exercise, stress
maritalstatus,reportedangina,history baseline,ofwhich24were100%occluded management training, smoking cessa-
ofmyocardialinfarction,height,weight, andwereexcludedapriorifromthele- tion, and group psychosocial support
numberofdiseasedlesions,andstenosis sion-changeanalysesperthestudypro- previously described in detail.3,7-10 Pa-
severityforallpatientswhowereran- tocol. Of the remaining 200 lesions, 14 tientswereencouragedtoavoidsimple
domized into the study but refused to werelosttothe4-yearfollow-up,asfol- sugars and to emphasize the intake of
participate.Wedidnotexcludeanyex- lows: in the experimental group, 2 le- complexcarbohydratesandotherwhole
perimental group patients who volun- sionswereexcludedduetotechnicalfail- foods.Only1patientintheexperimental
teeredevenifwedoubtedtheirabilityto ure during the angiogram and 2 had groupwasactivelysmokingatbaseline,
adheretothelifestyleprogram.Allpa- viewsthatdidnotmatch;inthecontrol andshequitatentry.Controlgrouppa-
tientswhovolunteeredwerefollowedup group,viewsdidnotmatchfor3lesions, tientswereaskedtofollowtheadviceof
usingtheintention-to-treatprinciple. 3lesionswereexcludedduetotechnical theirpersonalphysiciansregardinglife-
After 1 year, 7 patients did not pro- failure, 1 was excluded due to angio- stylechanges.
videangiographicdata,andthereasons plasty,and3wereexcludedduetocoro-
forlosstofollow-uphavebeenreported.3 naryarterybypasssurgery.Ofthe186 StatisticalMethods
Oftheremaining41patientsatbaseline lesionsavailableforanalysisat4years, Wedecidedaprioritousepercentdi-
mosthadseverecoronaryatherosclero- 109werefromtheexperimentalgroup ameterstenosisastheprimarydepen-
sis: 28 had 3-vessel disease, 12 had and77werefromthecontrolgroup. dent variable. Statistical methods to
2-vessel disease, and 1 had 1-vessel The1-yearoriginalstudyandthe4- comparethe2groupswerepreviously
disease. Two of these patients whose year extension were approved by the described.3Analysisofadherencevari-
angiographicdatawerenotusableafter committeesonhumanresearchatCali- ables and risk factor levels used time-
1 year agreed to undergo quantitative forniaPacificMedicalCenterandUni- structuredrepeatedmeasuresinwhich
coronary arteriography after 5 years; versityofCalifornia,SanFrancisco,and levels from all 3 measurement times
theseresultsareincludedinthebaseline each patient signed a written consent (baseline,1year,and5years)werein-
2002 JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
Table2.—AdherencetoExercise,StressManagement,andDietaryGuidelines
Mean(SEM)atBaseline Mean(SEM)at1Year Mean(SEM)at5Years
Experimental Control Experimental Control PValue* Experimental Control PValue*
(n=20) (n=15) (n=20) (n=15) Baseline-1Year (n=20) (n=15) Baseline-5Years
Exercise
Timesperweek 2.66(0.84) 2.38(0.77) 4.97(0.35) 2.87(0.70) .06 4.34(0.49) 3.57(0.56) .64
Hoursperweek 2.26(0.85) 2.42(0.99) 5.02(0.61) 2.52(0.70) .12 3.56(0.56) 2.90(0.65) .50
Stressmanagement
Timesperweek 0.70(0.41) 0.15(0.10) 8.22(0.73) 0.49(0.25) (cid:44).001 4.93(1.02) 0.74(0.39) (cid:44).001
Minutesperday 6.01(3.56) 1.71(1.19) 87.25(7.85) 4.47(2.79) (cid:44).001 48.53(10.36) 8.44(6.11) .001
Fatintake
Gramsperday 63.67(4.35) 57.42(5.94) 12.71(1.06) 52.38(5.31) (cid:44).001 17.34(2.30) 44.09(6.66) (cid:44).001
%ofEnergyintake 29.71(1.8) 30.52(2.9) 6.22(0.3) 28.76(2.3) (cid:44).001 8.51(1.0) 25.03(2.7) (cid:44).001
Dietarycholesterol,mmol/L[mg/dL] 5.47(0.672) 5.49(0.908) 0.08(0.002) 4.69(0.636) (cid:44).001 0.48(0.140) 3.59(0.641) .002
[211.4(26.0)] [212.5(35.1)] [3.3(0.8)] [181.3(24.6)] [18.6(5.4)] [138.7(24.8)]
Energyintake,J/d 8159(473) 7159(489) 7623(473) 7004(489) .64 7724(485) 6581(489) .86
Totaladherencescore† 0.62(0.08) 0.60(0.07) 1.29(0.08) 0.64(0.07) (cid:44).001 1.06(0.08) 0.72(0.07) (cid:44).001
*AllPlevelsare2-tailedandeachisaresultofatestofthenullhypothesisthatthechangebetween2particularvisits(eg,baselineand1year)doesnotdifferbetween
theexperimentalandcontrolgroups.
†Percentageofminimumrecommendedlevelofcombinedlifestylechange;includesalltheaboveplussmokingcessation.
Table3.—BaselineLevels,1-Year,and5-YearChangeScoresinCoronaryArteryLesions*
MeanatBaseline(95%CI) ChangeScoresat1Year(95%CI) ChangeScoresat5Years(95%CI)
Experimental Control Experimental Control PValue† Experimental Control PValue†
(n=20) (n=15) (n=18) (n=15) Baseline-1Year (n=20) (n=15) Baseline-5Years
Diameterstenosis,% 38.92 42.50 −1.75 2.28 .02 −3.07 11.77 .001
(35.29to42.54) (38.18to46.81) (−4.08to0.58) (−3.0to4.86) (−5.91to−0.24) (3.40to20.14)
Minimumdiameter,mm 1.64 1.74 0.01 −0.12 .11 0.001 −0.34 .05
(1.44to1.84) (1.50to1.97) (−0.10to0.12) (−0.25to−0.001) (−0.11to0.11) (−0.66to−0.02)
Normaldiameter,mm 2.65 2.96 −0.06 −0.10 .68 −0.13 0.045 .01
(2.39to2.92) (2.64to3.27) (−0.16to0.03) (−0.27to0.06) (−0.26to0.01) (0.017to0.072)
*CIindicatesconfidenceinterval.
†AllPlevelsare2-tailedandeachisaresultofatestofthenullhypothesisthatthechangebetween2particularvisits(eg,baselineand1year)doesnotdifferbetween
theexperimentalandcontrolgroups.
cludedinasingleregressionmodel.Sta- volunteeredinallavailabledataexcept by the square of the height in meters)
tisticalsignificancesofgroupdifferences thosewhovolunteeredweremorelikely (28.4vs25.4kg/m2;P=.03)andhadlower
wereobtainedforbaselinelevels,1-year tohaveahistoryofangina(87%vs65%; high-densitylipoprotein(HDL)choles-
changes, and 5-year changes using F P=.02),agreaternumberoflesions(4.5 terollevels(1.04mmol/L[40.1mg/dL]vs
tests. All repeated measures analyses vs 3.5; P=.04), and slightly more se- 1.36 mmol/L [52.4 mg/dL]; P=.04),
wereimplementedusingPROCMIXED verelystenosedlesions(2.3vs2.0ona whichwasalsoreflectedinlowerapoli-
underSASversion6.08.11Analysisofle- 3-pointscale;P=.05). poproteinA-Ilevels(3.45mmol/L[133.1
sion data used a repeated measures mg/dL] vs 4.08 mmol/L [157.5 mg/dL];
modelinwhichtherepeatedmeasures BaselineComparisons P=.03).Thelowerbodymassindexin
werebaselineorchangevaluesformul- ofExperimentalGroup the control group may be due to the
tiplelesionswithineachsubject.Change WithControlGroup largernumberofwomeninthecontrol
scoreswereusedforthebaselineto1- Analysesacrossthe35volunteersat group.Otherlipidvalues,includingra-
yearandbaselineto5-yearfollow-uppe- baseline for whom 4-year lesion data tiosoftotalcholesteroltoHDLandLDL
riods,andanalysisofbaselinelevels,1- wereavailableshowednosignificantdif- to HDL, did not differ significantly at
yearchanges,and5-yearchangeswere ferences between the experimental baseline(Table4).
doneseparately.Again,Ftestsprovided group and the control group in demo-
bySASPROCMIXEDwereusedtotest graphiccharacteristics,historyofmyo- ProgramAdherence
significance of differences between cardial infarction, angioplasty, bypass Intheexperimentalgroup,adherence
groups with respect to baseline levels, surgery,lesionnumber,lesionstenosis, toallaspectsoftheprogramwasexcel-
1-yearchanges,and5-yearchanges.The dietary fat or cholesterol intake, exer- lentduringthefirstyearandgoodafter5
SASPROCMIXEDlinearregression, cise and stress management practice, years, whereas control group patients
which allowed for dependence in data, blood pressure, exercise capacity, and maintainedmoremoderatechangesdur-
wasusedtodeterminetherelationship psychosocialmeasures(Tables1-3). ingthe5yearsconsistentwithconven-
between adherence and percent diam- Amongthemanycomparisons,onlya tionalguidelines(Table2).Thepercent-
eterstenosischanges.Relativeratesfor fewdifferedsignificantly(P(cid:44).05).More ageofdailyenergy(calories)providedby
cardiaceventswereanalyzedandtested womenwererandomlyassignedtothe fruits, vegetables, whole grains, soy,
byPoissonregressionusingexacttests controlgroup(4)thantotheexperimen- otherlegumes,nonfatdairy,andalcohol
(Stata5.0,CollegeStation,Tex). talgroup(1);thisfactaccountedforhalf wascomparableat1yearandat5years.
the weight difference (10 kg) between In the experimental group, fat intake
RESULTS
the2groupsandmostoftheheightdif- decreased from approximately 30% to
BaselineComparisons
ference(6cm). 8.5%,cholesterolfrom211to18.6mg/d,
ofVolunteersWithRefusals
Experimental group patients had a energy from 8159 to 7724 J (1950-1846
Thosewhodeclinedtheinvitationto slightly larger body mass index (mea- cal),proteinfrom17%to15%,andcarbo-
beinthestudyweresimilartothosewho suredastheweightinkilogramsdivided hydratesincreasedfrom53%to76.5%.In
JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal 2003
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
Table4.—ChangesinRiskFactors
Mean(SEM)atBaseline Mean(SEM)at1Year
Experimental Control Experimental Control
RiskFactor (n=20) (n=15) (n=20) (n=15)
Serumlipids,mmol/L[mg/dL]
Totalcholesterol 5.83(0.31)[225.1(11.9)] 6.42(0.24)[247.9(9.4)] 4.22(0.22)[162.9(8.4)] 6.33(0.38)[244.3(14.7)]
Low-densitylipoprotein 3.72(0.29)[143.80(11.21)] 4.30(0.19)[166.40(7.46)] 2.24(0.24)[86.56(9.41)] 4.25(0.38)[164.13(14.85)]
High-densitylipoprotein 1.04(0.07)[40.05(2.78)] 1.36(0.14)[52.36(5.54)] 0.94(0.10)[36.28(3.81)] 1.34(0.10)[51.87(3.81)]
Triglyceride 5.90(0.69)[227.8(26.5)] 5.78(1.63)[223.3(63.0)] 6.69(0.75)[258.2(29.1)] 4.30(0.40)[166.1(15.5)]
Apolipoproteins,g/L
A-I 1.331(0.046) 1.575(0.092) 1.308(0.057) 1.761(0.121)
B 1.000(0.054) 1.024(0.062) 0.7685(0.046) 1.085(0.053)
Bloodpressure,mmHg
Systolic 135.3(4.0) 137.2(4.5) 126.4(3.9) 128.8(4.5)
Diastolic 81.70(2.05) 80.27(3.15) 77.03(2.01) 75.07(8.15)
Weight,kg 91.40(3.42) 75.74(4.37) 80.64(2.48) 77.18(4.73)
*AllPlevelsare2-tailedandeachisaresultofatestofthenullhypothesisthatthechangebetween2particularvisits(eg,baselineand1year)doesnotdifferbetween
theexperimentalandcontrolgroups.
Table5.—ReportedAnginaSymptoms
Mean(SD)atBaseline Mean(SD)at1Year Mean(SD)at5Years
Experimental Control Experimental Control PValue* Experimental Control PValue*
(n=18) (n=14) (n=18) (n=14) Baseline-1Year (n=18) (n=14) Baseline-5Years
Chestpainfrequency,timesperweek 5.8(14.7) 1.4(1.8) 0.5(0.8) 4.0(9.3) .08 1.6(2.7) 0.9(1.9) .32
Chestpainduration,min 3.1(4.8) 3.2(8.4) 1.8(4.7) 7.6(15.9) .11 0.9(1.3) 1.0(2.7) .93
Chestpainseverity(1-7scale) 1.5(1.5) 0.6(0.8) 0.7(1.2) 1.4(1.2) (cid:44).001 0.9(1.4) 0.6(1.1) .29
*AllPlevelsare2-tailedandeachisaresultofatestofthenullhypothesisthatthechangebetween2particularvisits(eg,baselineand1year)doesnotdifferbetween
theexperimentalandcontrolgroups.
the control group, fat intake decreased A-Ididnotchangeintheexperimental 4.5%relativeimprovement)andby3.1
from30%to25%,cholesterolfrom212.5 group, but it increased in the control absolutepercentagepointsafter5years
to138.7mg/d,energyfrom5.49to3.59J group(P=.04).High-densitylipoprotein (a7.9%relativeimprovement).Incon-
(1711-1573cal),proteinfrom19%to18%, levelsandbloodpressuredidnotdiffer trast,theaveragepercentdiameterste-
andcarbohydratesincreasedfrom51%to betweenthe2groups. nosisinthecontrolgroupincreasedby
52%. Since patients volunteered origi- 2.3percentagepointsafter1year(a5.4%
AnginaPectoris
nallyonlyfora1-yearstudy,therewasa relativeworsening)andby11.8percent-
significant decrease in meeting atten- Experimental group patients had a agepointsafter5years(a27.7%relative
danceafter1yearfor4ofthepatients. 91%reductioninreportedfrequencyof worsening). These between-group dif-
Walkingwastherecommendedformof anginaafter1yearanda72%reduction ferenceswerestatisticallysignificantaf-
exercise,butsomepatientsjoggedordid after5years(Table5).Incontrast,con- terboth1yearand5years(P=.02and
morestrenuousexercise. trolgrouppatientshada186%increase P=.001,respectively,Figure1).
inreportedfrequencyofanginaafter1 Figure 2 shows the experimental
RiskFactorChanges
year and a 36% decrease in frequency groupchangesinpercentdiameterste-
Patients in the experimental group after5years.Thedecreaseinanginain nosisfrombaselineto5yearsaccording
lost10.9kg(23.9lbs)at1yearandsus- the control group after 5 years was in totertilesofadherencetothelifestyle
tainedaweightlossof5.8kg(12.8lbs)at large part because 3 of the 5 patients intervention. As seen at 1 year,3 there
5years,whereasweightinthecontrol whoreportedanincreaseinanginalepi- was also a strong correlation between
group changed little from baseline. In sodesfrombaselineto1yearunderwent adherenceandpercentdiametersteno-
the experimental group, LDL choles- coronaryangioplastybetweenyears1 sisafter5yearsinadose-responserela-
terollevelsdecreasedby40%at1year and5.Becauseofthisreductioninangina tionship;thetertileofpatientsthatwas
and remained 20% below baseline at 5 in control group patients who under- mostadherenttotheprogramhadthe
years.Inthecontrolgroup,LDLcholes- went revascularization, the between- mostregression,thetertilewithinter-
terollevelsdecreasedby1.2%at1year groupdifferenceswerenolongersignifi- mediateadherencehadlessregression,
andby19.3%at5years.Therewereno cantafter5years(Table5). andthetertilewiththeleastadherence
statistically significant differences in haltedtheprogressionofdiseasewith-
AngiographicChanges
LDL levels between the 2 groups at 5 out regression (P=.04). Of interest is
years, primarily because 9 (60%) of Alldetectablelesionsthatmatchedat thatthisrelationshipwasnotrelatedto
15 control patients took lipid-lowering baselineand5-yearfollow-upandwere age or disease severity. There was no
drugsbetweenyear1andyear5ofthe not100%occludedatbaselinewerein- significantrelationshipbetweenadher-
study.Noneoftheexperimentalgroup cludedintheanalyses(n=186).Atbase- ence and lesion changes in the control
patientstooklipid-loweringdrugsdur- line, there were no significant differ- group, perhaps because many of these
ing the 5 years of the study. Fourteen ences between the experimental and patients began taking lipid-lowering
patientsintheexperimentalgroupand controlgroupsinanymeasureoflesion drugs,whichmayhaveconfoundedthe
11patientsinthecontrolgrouptookas- severity(Table3).Intheexperimental abilitytodetectapossiblerelationship.
pirinduringthestudy. group, the average percent diameter Indeed, we found significant correla-
Triglycerides did not change signifi- stenosis at baseline decreased 1.75 ab- tions between changes in lipid levels
cantly in either group. Apolipoprotein solutepercentagepointsafter1year(a (LDLandtotalcholesterol)andchanges
2004 JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
60
55
50
45
40
35
inlesionsinbothgroups.Thesecorrela- duction(continuedimprovement)after 30
tionsremainedsignificantwhenexam- 5yearsthanafter1yearinexperimental
iningeitherthelipidvaluesat5yearsor grouppatientswhowereaskedtomake
thechangeinlipidvaluesfrombaseline intensivelifestylechanges.Incontrast,
to5years. control group patients showed much
Asasecondaryanalysis,weexamined moreprogression(continuedworsening)
theresultsincontrolgrouppatientswho inaveragepercentdiameterstenosisaf-
begantakinglipid-loweringdrugsduring ter5yearsthanafter1year,eventhough
thestudy.Percentdiameterstenosispro- morethanhalfofthecontrolgrouppa-
gressedfrom45.7%to51.7%,achangeof tients were prescribed lipid-lowering
6.0absolutepercentagepoints.Inthecon- medications during the course of the
trolpatientswhodidnottakelipid-low- study. Although the sample size was
eringdrugsthediseaseprogressedfrom relativesmall,12thesedifferenceswere
40.7%to59.7%,amuchgreaterchangeof statistically significant at both 1 year
19.0absolutepercentagepoints.(Noex- and5years.Thesefindingssupportthe
perimentalgrouppatientstooklipid-low- feasibilityofintensivelifestylechanges
eringdrugsduringthestudy.) in delaying, stopping, or reversing the
Thechangeinbodymassindexfrom progressionofcoronaryarterydisease
baseline to 1 year (r=−0.85; P(cid:44).001) inambulatorypatientsoverprolonged
andfrombaselineto5years(r=−0.72; periods.
P=.001)wassignificantlycorrelatedwith We found more than twice as many
thechangeinpercentdiameterstenosis cardiaceventsperpatientinthecontrol
inthecontrolgrouponly.Inotherwords, group than in the experimental group.
thosewhogainedweightweremorelikely Thesefindingsareconsistentwithother
toshowprogressionofatherosclerosis. clinical trials showing that even small
changesinpercentdiameterstenosisare
CardiacEvents
often accompanied by marked reduc-
Dataoncardiaceventswereobtained tionsincardiacevents.13-16Otherstudies
fromall48patients.Cardiaceventsin- have demonstrated how quickly the
cluded myocardial infarction, coronary coronaryarteryendotheliumstabilizes
angioplasty,coronaryarterybypasssur- inresponsetolipid-loweringdrugs.17,18
gery, cardiac-related hospitalizations, Althoughtherewassomereductionin
andcardiac-relateddeaths.At5years, adherencetotheintensivelifestylein-
there were more cardiac events in the terventionbetweenyears1and5inthe
controlgroup(45eventsfor20patients, experimental group, long-term adher- population.19Incontrast,theStepIIdiet
or2.25eventsperpatient)thantheex- enceremainedremarkablyhighinthis reducesLDLcholesterolbyonly5%or
perimentalgroup(25eventsfor28pa- sample of self-selected patients. The less.20,21
tients,or0.89eventsperpatient)(Table leveloflifestylechange,evenat5years, High-density lipoprotein levels de-
6). Control group patients were more is greater than in any other published creased and triglycerides increased in
likelytohaveundergonecoronaryangi- studyofambulatorypopulations.These experimentalgrouppatientsoverall,al-
oplasty and bypass surgery and/or to results are especially encouraging be- though the ratio of LDL to HDL was
have been hospitalized for cardiac-re- cause these patients initially volun- improved. Recent reports assert that
latedproblemsthanwereexperimental teered to participate for only 1 year thisphenomenon,whichisoftenseenin
grouppatients. whentheyenteredthestudy. very low-fat diets, may be harmful.22,23
TheexperimentalgroupreducedLDL However, patients in the Lifestyle
COMMENT
cholesterollevelsby40%at1yearandby HeartTrialshowedevenmoreregres-
Theprimaryendpointofthisstudy, 20% after 5 years; these reductions are sionofcoronaryatherosclerosisafter5
chosen a priori, was percent diameter comparable with those achieved with yearsthanafter1yearaswellassignifi-
stenosis.Onaverage,therewasmorere- lipid-lowering drugs in an ambulatory cantly decreased cardiac events. Low
%
,sisonetS
retemaiD
†
51.9
Control
*
41.3 42.3
40.7
38.5 37.3
Treatment
Baseline 1 y 5 y
Figure1.—Meanpercentagediameterstenosisin
treatmentandcontrolgroupsatbaseline,1year,
and5years.ErrorbarsrepresentSEM;asterisk,
P=.02 by between-group 2-tailed test; dagger,
P=.001bybetween-group2-tailedtest.
–8
–7
–6
–5
–4
–3
–2
–1
0
1
%
,)y
5 ot
enilesaB(
sisonetS
retemaiD
ni
segnahC
Mean(SEM)at5Years
PValue* Experimental Control PValue*
Baseline-1Year (n=20) (n=15) Baseline-5Years
.004 4.87(0.20)[188.0(7.8)] 5.62(0.20)[217.0(7.9)] .60
.003 2.99(0.20)[115.35(7.59)] 3.47(0.21)[133.80(8.25)] .76
.35 0.90(0.05)[34.75(2.03)] 1.28(0.12)[49.27(4.47)] .54
.17 6.11(0.59)[236.1(22.9)] 5.48(0.78)[211.5(30.2)] .78
.11 1.302(0.092) 1.839(0.139) .04
.004 1.014(0.072) 0.991(0.083) .63
.96 130.0(3.9) 123.3(4.7) .19
.91 76.63(2.01) 73.61(3.25) .74
.001 85.64(2.88) 77.09(4.5) .001
– 6.81
– 3.02
– 0.37
Most Medium Least
Adherence Adherence Adherence
(1.60-1.20) (1.18-0.83) (0.73-0.47)
[n = 6] [n = 7] [n = 6]
Figure2.—Changesinpercentagediametersteno-
sisby5-yearadherencetertilesfortheexperimen-
talgroup.
JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal 2005
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
Table6.—CardiacEventsDuring5-YearFollow-up etal29reportedthatasimilardietplus
lipid-loweringdrugsin11patientscaused
No.ofEvents
regressionof11lesionsandstabilization
Experimental* Control† Risk 95%Confidence P intheremaining14lesionsafter5.5years.
(n=28) (n=20) Ratio Interval Value Although there was no control group,
Myocardialinfarction 2 4 2.74 0.393-30.3 .26 thosewhowereadherenttothedietre-
Percutaneoustransluminal 8 14 2.40 0.939-6.60 (cid:44).05 portedsubstantiallyfewercardiacevents
coronaryangioplasty
thanthosewhowerenotadherent.29
Coronaryarterybypassgraft 2 5 3.43 0.561-36.0 .14
Cardiachospitalizations‡ 23 44 2.62 1.55-4.55 (cid:44).001 Like all clinical trials, our study has
limitations.Althoughthestudypartici-
Deaths 2 1 0.685 0.012-13.2 .81
Anyevent 25 45 2.47 1.48-4.20 (cid:44).001 pants were a diverse group, they may
not be representative of the general
*Person-yearsofobservationwas108.04. population of patients with coronary
†Person-yearsofobservationwas78.81.
‡Includesmyocardialinfarction,percutaneoustransluminalcoronaryangioplasty,andcoronaryarterybypass heartdisease.Halfofthepatientswho
graft. underwentquantitativecoronaryarte-
riographyintheparticipatoryhospitals
HDLcholesterollevelsduetoreduced eterremainedstableintheexperimental didnotmeetalloftheinclusionandex-
fatintakearetheresultofadecreased groupbutmarkedlynarrowedinthecon- clusioncriteriaandwerenotinvitedto
transportrateratherthantheincreased trolgroupduringthe5yearsofthestudy. participateinthestudy.Also,halfofthe
catabolismthatisresponsibleformost At5years,thedifferencesbetweenthe patients who were invited declined to
cases of low HDL cholesterol levels in experimentalandcontrolgroupswere enroll in the study. Nevertheless, it is
persons consuming a typical Western statisticallysignificantforbothpercent encouragingthat50%ofthepatientswho
diet.24 Populations consuming low-fat, diameterstenosisandminimumdiam- werecontactedagreedtovolunteerde-
plant-baseddietshavelowHDLcholes- eter, even though control group pa- spitetherequirementforrepeatedarte-
terol levels and low rates of coronary tientsreportedriskreductionbehavior riographyandthatexperimentalgroup
heartdisease.Ourdataprovideevidence consistentwithaStepIIdietoftheNa- patientswereabletomakeandmaintain
usingquantitativecoronaryarteriogra- tionalCholesterolEducationProgram comprehensive lifestyle changes. The
phyinthispopulationthatdiet-induced and the American Heart Association: angiographicmeasureslosttofollow-up
lowering of HDL cholesterol does not theyconsumedanaverageof25%ofen- mayhaveaffectedthetreatmentandcon-
conferthesameriskofatherosclerosis ergy(calories)fromfatandexercisedan trol groups differently, although there
as do low HDL cholesterol levels in averageof3.5timesperweek.Thesedata arenodatatosuggestthatthisoccurred.
Americansconsumingahigh-fatdiet.25 areconsistentwithotherstudiesindi- Inaddition,thereisapossibilityofdif-
Experimentalgrouppatientswhosetri- catingthatmoderatechangesindietand ferential loss of lesions in patients, al-
glycerides increased during the first lifestylemaynotbesufficienttostopthe thoughnoevidenceindicatesthatthisoc-
year were asked to minimize their in- progressionofcoronaryatherosclerosis curred;inbothgroups,therewere14le-
take of simple carbohydrates, and tri- unless combined with lipid-lowering sionsthatwerelosttofollow-up.Also,4
glyceridelevelsdecreasedbetweenyear drugs.27 lesionswerelostinthecontrolgroupto
1andyear5. After 5 years, the normal diameter bypass surgery or angioplasty; since
Theexperimentalgroup’smarkedre- (thesegmentofleastnarrowingproxi- theselesionswereworseningsufficiently
ductioninfrequency,severity,anddu- mal to the minimum diameter) de- to require revascularization, the exclu-
ration of angina after 1 year was sus- creased slightly in the experimental sionoftheselesionsfromanalysiswould
tainedatsimilarlevelsafter5years.This groupbutwidenedslightlyinthecontrol make between-group differences more
long-termreductioninanginaiscompa- group.Aslightdecreaseinnormaldiam- difficulttodetect.Werecentlycompleted
rablewiththatachievedfollowingcoro- eter,atleastuptoapoint,mayimprove a multicenter demonstration project to
nary artery bypass surgery or angio- myocardial perfusion by streamlining assessthepracticalityandcost-effective-
plastyandhelpstomaintainlong-term flow—decreasing the forward flow ness of this intervention in a larger
adherence.26Between-groupdifferences losses that occur when going from a sample of economically and geographi-
inmostmeasuresofchestpainwerenot largertoasharplyreducedlumendiam- cally diverse patients with coronary
statisticallysignificantafter5yearsbe- eter.4Conversely,theslightincreasein heartdisease.30
causetherewasalargevariabilityinan- thenormaldiameterandreductioninthe Although we did not use lipid-
gina and control group patients who minimumdiameterseenincontrolgroup lowering drugs in the experimental
werethemostsymptomaticunderwent patientsincreasedtheentryangle,fur- group, their value has been demon-
revascularization. therreducingbloodflow.Thesetheoreti- stratedinstudiesthathavebeenpub-
When we began this study, we be- cal considerations are consistent with lishedsincetheLifestyleHeartTrialbe-
lieved that the younger patients with the substantially increased myocardial gan. We do not know if experimental
milderdiseasewouldbemorelikelyto perfusionintheexperimentalgroupand grouppatientsmayhavedemonstrated
showregression,butwedidnotfindthis decreased myocardial perfusion in the even more improvement by including
tobetrue.Instead,wefoundthatthepri- control group that we measured using lipid-loweringdrugs.14-16Patientsinthe
marydeterminantofchangeinpercent cardiac positron emission tomography controlgroupwhowerenotprescribed
diameterstenosisintheexperimental scans.5 lipid-lowering drugs during the study
groupwasneitheragenordiseasese- A much earlier study by Morrison28 showedmorethan3timesasmuchpro-
verity but adherence to the recom- foundthatmoderatereductionsinfatand gressioninpercentdiameterstenosisas
mendedchangesindietandlifestyle.This cholesterolintakeimprovedcardiacsur- thosewhowere.Noexperimentalgroup
relationshipofadherencetopercentdi- vival:after12years,allofthecontrol patientstooklipid-loweringdrugsdur-
ameter stenosis in the experimental grouppatientshaddiedcomparedwith ingthestudy,yettheyshowedbetterre-
groupwasfoundafter1year3andalsoaf- only 62% of experimental group pa- sults than control group patients who
ter5yearsinadose-responserelation- tientsinanonrandomizedtrial.Morere- were taking these drugs. Lipid-
ship.Coronaryarteryminimumdiam- cently,animportantstudybyEsselstyn loweringdrugsareexpensive,compli-
2006 JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
anceisdifficulttoachieve,31andlong- manycardiaceventsaspatientsmaking GlennFoundation,SantaBarbara,Calif,Corporate
term safety is unknown.32 In practice, comprehensivelifestylechanges. PropertyInvestors,NewYork,NY,theSeretean
Foundation, Boca Raton, Fla, the Weatherhead
patientsmaybeofferedarangeofthera-
Foundation,Cleveland,theTexasCommerceBank
peutic options, including comprehen- Majorsupportforthisstudywasprovidedby Foundation,Houston,andArthurAndersen&Co,
sivelifestylechanges,lipid-loweringdrug grantsfromtheNationalHeart,Lung,andBlood Houston.
therapy, and revascularization, either Institute of the National Institutes of Health, Weareindebtedtothefollowingwhoperformed
Bethesda,Md(RO1HL42554),theDepartmentof quanitativecoronaryarteriographyforthisstudy:
separatelyorincombination. HealthServicesoftheStateofCalifornia,Sacra- Robert Bernstein, MD, Craig Brandman, MD,
In summary, these ambulatory pa- mento(1256SC-01),TheHenryJ.KaiserFamily BruceBrent,MD,RalphClark,MD,KeithCohn,
tientswereabletomakeandmaintain Foundation,MenloPark,Calif,GeraldD.HinesIn- MD,JamesCullen,MD,RichardFrancoz,MD,Kent
comprehensivechangesindietandlife- terests,Houston,Tex,HoustonEndowmentInc, Gershengorn,MD,GabrielGregoatos,MD,Lester
Houston,TheJohnE.FetzerInstitute,Kalamazoo, Jacobsen, MD, Myron Marx, MD, Patricia McK-
stylefor5yearsandshowedevenmore Mich, The Nathan Cummings Foundation, New enna,MD,RoyMeyer,MD,GeraldNeedleman,MD,
regressionofcoronaryatherosclerosisaf- York, NY, The Bucksbaum Foundation, Des Gene Shafton, MD, Brian Strunk, MD, Anne
ter 5 years than after 1 year as mea- Moines,Iowa,GrossFoundation,Houston,Pritzker Thorson,MD,andJohnWack,MD,aswellasthe
suredbypercentdiameterstenosis.In Foundation,Chicago,Ill,TheEnronFoundation, headangiographynursesGeorgieHesse,RN,and
Houston,theMilkenFamilyFoundation,LosAn- LaVeta Luce, RN. Dale Jones, RT, and Yvonne
contrast,patientsfollowingmorecon- geles,Calif,TheBomerFoundation,Houston,Con- Stuart,RT,providedtechnicalsupportforthearte-
ventional lifestyle recommendations tinentalAirlines,Houston,theCreditSuisseFirst riographicanalyses.SpecialappreciationtoJean-
showedevenmoreprogressionofcoro- BostonFoundation,NewYork,theGroppeFoun- Marc Fullsack for food services and to Marjorie
naryatherosclerosisafter5yearsthan dation,Houston,theRayC.FishFoundation,Hous- McClain and Myrna Melling for administrative
ton, the Moldaw Philanthropic Fund, Atherton, support.
after1year,andhadmorethantwiceas Calif,theDawsonFoundation,Cleveland,Ohio,the
References
1. OrnishDM,ScherwitzLW,DoodyRS,etal.Ef- 12. OrnishD.Moreonlow-fatdiets.NEnglJMed. womenwithlowlevelsofHDL-Candhighlevelsof
fectsofstressmanagementtraininganddietary 1998;338:1623-1624. LDLcholesterol.NEnglJMed.1998;339:12-20.
changesintreatingischemicheartdisease.JAMA. 13. BrownBG,AlbertsJJ,FisherLD,etal.Regres- 22. KatanMB,GrundySM,WillettWC.Shoulda
1983;249:54-59. sionofcoronaryarterydiseaseasaresultofintensive low-fat,high-carbohydratedietberecommendedfor
2. OrnishDM,GottoAM,MillerRR,etal.Effectsof lipid-loweringtherapyinmenwithhighlevelsofapo- everyone?beyondlow-fatdiets.NEnglJMed.1997;
avegetariandietandselectedyogatechniquesin lipoproteinB.NEnglJMed.1990;323:1289-1298. 337:563-567.
thetreatmentofcoronaryheartdisease[abstract]. 14. JukemaJW,BruschkeAVG,VanBovenAJ,et 23. LichtensteinAH,VanHornL.Verylowfatdi-
ClinRes.1979;27:720A. al.Effectsoflipidloweringbypravastatinonpro- ets:AHAScienceAdvisory.Circulation.1998;98:
3. OrnishDM,BrownSE,ScherwitzLW,etal.Can gressionandregressionofcoronaryarterydisease 935-939.
lifestylechangesreversecoronaryatherosclerosis? insymptomaticmenwithnormaltomoderatelyel- 24. BrintonEA,EisenbergS,BreslowJL.Alow-
TheLifestyleHeartTrial.Lancet.1990;336:129-133. evatedserumcholesterollevels.Circulation.1995; fatdietdecreaseshighdensitylipoprotein(HDL)
4. GouldKL,OrnishD,KirkeeideR,etal.Improved 91:2528-2540. cholesterollevelsbydecreasingHDLapolipopro-
stenosisgeometrybyquantitativecoronaryarteri- 15. Scandinavian Simvastatin Survival Study teintransportrates.JClinInvest.1990;85:144-151.
ographyaftervigorousriskfactormodification.Am Group.Randomizedtrialofcholesterolloweringin 25. ConnorWE,ConnorSL.Shouldalow-fat,high-
JCardiol.1992;69:845-853. 4444patientswithcoronaryheartdisease.Lancet. carbohydratedietberecommendedforeveryone?
5. GouldKL,OrnishD,ScherwitzL,etal.Changes 1994;344:1383-1389. the case for a low-fat, high-carbohydrate diet.
inmyocardialperfusionabnormalitiesbypositron 16. HaskellWL,AldermanEL,FairJM,etal.Ef- NEnglJMed.1997;337:562-563,566.
emissiontomographyafterlong-term,intenserisk fectsofintensivemultipleriskfactorreductionon 26. KingSBIII,LemboNJ,WeintraubWS,etal.A
factormodification.JAMA.1995;274:894-901. coronaryatherosclerosisandclinicalcardiacevents randomizedtrialcomparingcoronaryangioplasty
6. StuffJE,GarzaC,SmithEO,etal.Acomparison inmenandwomenwithcoronaryarterydisease. withcoronarybypasssurgery:EmoryAngioplasty
ofdietarymethodsinnutritionalstudies.AmJClin Circulation.1994;89:975-990. versusSurgeryTrial(EAST).NEnglJMed.1994;
Nutr.1983;37:300-306. 17. Via JA,TreasureCB,NabelEG,etal.Coro- 331:1044-1050.
7. OrnishD.ReversingHeartDisease.NewYork, naryvasomotorresponsetoacetylcholinerelatesto 27. OrnishD.Dietarytreatmentofhyperlipidemia.
NY:BallantineBooks;1992. riskfactorsforcoronaryarterydisease.Circula- JCardiovascRisk.1994;1:283-286.
8. BillingsJ,ScherwitzL,SullivanR,OrnishD. tion.1990;81:491-497. 28. MorrisonLM.Dietincoronaryatherosclerosis.
GroupsupporttherapyintheLifestyleHeartTrial. 18. HarrisonDG,ArmstrongML,FreimannPC,et JAMA.1960;173:884-888.
In:ScheidtS,AllanR,eds.HeartandMind:The al.Restorationofendothelium-dependentarterial 29. Esselstyn CB Jr, Ellis SG, Medendorp SV,
Emergence of Cardiac Psychology.Washington, relaxationbydietarytreatmentofatherosclerosis. CroweTD.Astrategytoarrestandreversecoro-
DC: American Psychological Association; 1996: Circulation.1987;80:1808-1811. naryarterydisease:a5-yearlongitudinalstudyofa
233-253. 19. ShepherdJ,CobbeSM,FordI,etal.Prevention singlephysician’spractice.JFamPract.1995;41:
9. MoyersB.Changinglifehabits:aconversation ofcoronaryheartdiseasewithpravastatininmen 560-568.
withDeanOrnish.In:HealingandtheMind.New withhypercholesterolemia.NEnglJMed.1995;333: 30. OrnishD.Avoidingrevascularizationwithlife-
York,NY:Doubleday&CoInc;1993. 1301-1307. stylechanges:TheMulticenterLifestyleDemon-
10. AmericanCollegeofSportsMedicine.Guide- 20. HunninghakeDB,SteinEA,DujovneCA,etal. strationProject.AmJCardiol.1998;82:72T-76T.
linesforExerciseTestingandPrescription.Phila- Theefficacyofintensivedietarytherapyaloneor 31. AvornJ,MonetteJ,LacourA,etal.Persistence
delphia,Pa:Lea&Febiger;1986. combinedwithlovastatininoutpatientswithhyper- ofuseoflipid-loweringmedications.JAMA.1998;
11. SASInstituteInc.SAS/STAT,Version6.08: cholesterolemia.NEnglJMed.1993;328:1213-1219. 279:1458-1462.
ChangesandEnhancements,SASTechnicalRe- 21. StefanickML,MackeyS,SheehanM,etal.Ef- 32. Newman TB, Hulley SB. Carcinogenicity of
portP-229.Cary,NC:SASInstitute;1992. fectsofdietandexerciseinmenandpostmenopausal lipid-loweringdrugs.JAMA.1996;275:55-60.
JAMA,December16,1998—Vol280,No.23 LifestyleHeartTrial—Ornishetal 2007
©1998AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
LETTERS
counselingandtestingdatasystemwasbegun,and1(Florida) inthepopulation.Ourresultsaresupportedbyarecentstudy
began HIV reporting very recently and not enough time has ofmorethan2500peopleinhigh-riskgroups(MSM,IDUs,and
elapsedtohaveadequatedataforanalysis.Theyear-to-yearme- attendeesofsexuallytransmitteddiseaseclinics)in9states.4In
dianpercentagechangesintotalnumberofHIVtestsduring thisstudy,morethan60%ofparticipantswereunawareoftheir
1992through1996forareaswithandwithoutHIVreporting state’sHIVreportingpolicyand,ofthoseavoidingtesting,only
weresimilarinmagnitudeandtrend.2 2%statedthatreportingwasamainfactorfornotbeingtested.4
AlthoughweshowednolargedeclinesintestingamongMSM Furthermore,asDrPaulandcolleaguesdemonstratedinNew
andotherriskgroupsafterHIVreporting,weagreewithArago´n Jersey,largenumbersofpeopledidnotgotonearbystatestobe
andMyersandDrWoodsandcolleaguesthattrendsinsomesub- testedafterHIVreportingwasimplemented.
groups—forexample,inasmallnumberofMSMconcernedwith AllynK.Nakashima,MD
reportingissues—couldbehiddenwithinthelargercommunity RosemarieHorsley
ofMSM.Becausetherewillalwaysbeindividualsconcernedabout RobertL.Frey,PhD
theseissues,weemphasizedtheimportanceofmakinganony- PatriciaA.Sweeney,MPH
J.ToddWeber,MD
moustestingavailabletopromoteknowledgeofHIVstatusamong
PatriciaL.Fleming,PhD
at-riskpeople.TheapprovalbytheUSFoodandDrugAdmin-
CentersforDiseaseControlandPrevention
istrationofhomesamplecollectiontestsforHIVexpandstheavail-
Atlanta,Ga
abilityofanonymoustestinginallareas.3
1. CentersforDiseaseControlandPrevention.HIV/AIDSSurveillanceReport.At-
Woods et al also state that, except for New Jersey, we in- lanta,Ga:CentersforDiseaseControlandPrevention;1997;9(No.2):32.
cluded only low-prevalence states. This is incorrect. Louisi- 2. CentersforDiseaseControlandPrevention.HIVCounselingandTestingin
PubliclyFundedSites:1996AnnualReport.Atlanta,Ga:CentersforDiseaseCon-
ana(acquiredimmunodeficiencysyndrome[AIDS]rateof33.7 trolandPrevention;1998:17.
per100000in1997)andTennessee(25.1per100000)have 3. BransonB.HomesamplecollectiontestsforHIVinfection.JAMA.1998;280:
1699-1701.
highAIDSincidence,comparablewiththeirownstateofCali-
4. CentersforDiseaseControlandPrevention.HIVtestingamongpopulationsat
fornia (29.8 per 100000)1 and are considered moderate- riskforHIVinninestates:resultsfromtheHIVtestingsurvey(HITS),November
1995-December1996.MMWRMorbMortalWklyRep.1998;47:1086-1091.
prevalencestates.
DrSolomonandcolleaguesareconcernedthatthestudyde-
signwasecologicalandsubjecttothefallacyinherentinsuch
studies,ie,thatecologicalcorrelationscannotbevalidlysubsti- CORRECTIONS
tutedforindividualcorrelations.However,todemonstratethe
impactofapolicychangeonalargepopulation,ecologicalmeth- AuthorOmitted: IntheOriginalContributionentitled“IntensiveLifestyleChanges
forReversalofCoronaryHeartDisease”publishedintheDecember16,1998,is-
odsmaybethemostpracticaldesign.Inanindividual-levelstudy, sueofTHEJOURNAL(1998;280:2001-2007),thenameofShirleyE.Brown,MD,
eachindividual’sawarenessofthechangeinpolicywouldbede- wasomittedfromthelistofauthors.Thefulllistofauthorsshouldread“Dean
Ornish,MD;LarryW.Scherwitz,PhD;JamesH.Billings,PhD,MPH;ShirleyE.Brown,
termined.Onapopulationbasis,thiswouldbeadifficultstudy
MD;K.LanceGould,MD;TerriA.Merritt,MS;StephenSparler,MA;WilliamT.
toconduct,especiallyifattitudesofhigh-riskpersonswereto Armstrong,MD;ThomasA.Ports,MD;RichardL.Kirkeeide,PhD;CharissaHo-
geboom,PhD;RichardJ.Brand,PhD.”
beassessed.Althoughourstudycannotdistinguishbetween
people who were aware (“exposed”) and unaware (“not ex- IncorrectLocation: IntheMSJAMAEssayentitled“Physician-Legislators:Physi-
posed”)ofthechangeinreportingpolicy,theimportantfactre- ciansPracticingPublicService”publishedintheMarch3,1999,issueofTHE
JOURNAL(1999;281:862),CongressmanVicSnyderwaslistedasrepresenting
mainsthatnolargechangesintestingbehaviorwereobserved Arizonawhen,infact,herepresentsArkansas.
1380 JAMA,April21,1999—Vol281,No.15 ©1999AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://jama.jamanetwork.com/ by a Eastern Kentucky University User on 05/25/2015
